Epidemiological studies of CHD and the evolution of preventive cardiology

Nature Reviews Cardiology

Volumn 11, Issue 5, 2014, Pages 276-289

  Wong, Nathan D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CARDIOLOGY; CARDIOVASCULAR RISK; DISEASE COURSE; GENETIC ASSOCIATION; HEART PROTECTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; META ANALYSIS (TOPIC); POPULATION RESEARCH; PREVENTIVE MEDICINE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; ADVERSE EFFECTS; ALGORITHM; BODY MASS; CARDIOVASCULAR DISEASES; COMPLICATION; CORONARY DISEASE; DIABETES COMPLICATIONS; EVIDENCE BASED MEDICINE; HEALTH; HYPERCHOLESTEROLEMIA; HYPERTENSION; OBESITY; PREVALENCE; SEX RATIO; SMOKING; SURVIVAL RATE;

ALGORITHMS; BODY MASS INDEX; CARDIOLOGY; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIABETES COMPLICATIONS; EVIDENCE-BASED MEDICINE; GLOBAL HEALTH; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; OBESITY; OVERWEIGHT; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SMOKING; SURVIVAL RATE;

EID: 84899653856     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2014.26     Document Type: Review

References (136)

1. Mendis, S., Puska, P. & Norrving, B. (Eds) Global Atlas on Cardiovascular Disease Prevention and Control (WHO, 2011
2. Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128 (2012
3. Lim, S. S. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224-2260 (2012
4. Go, A. S. et al. Heart Disease and Stoke Statistics-2014 update: A report from the American Heart Association. Circulation 129, e28-e292 (2014
5. Hirsch, A. (Translated by Creighton, C.) Handbook of Geographical and Historical Pathology (The New Sydenham Society, 1883
6. Anitschkow, N. in Deuxième Conférence Internationale de Pathologie Géographique, Utrecht, 26-28 Juillet 1934 (ed. Askanazy, M.) 44-101 (Oosthoek, 1935
7. Keys, A. et al. Coronary heart disease among Minnesota business and professional men followed fifteen years. Circulation 28, 381-395 (1963
8. Keys, A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease (Harvard University Press, 1980
9. Keys, A. & White, P. D. (Eds) Cardiovascular Epidemiology (Paul B. Hoeber, Publishers, 1956
10. Epstein, F. H. Cardiovascular disease epidemiology: A journal from the past into the future. Circulation 93, 1755-1764 (1996
11. Keys, A. Atherosclerosis: A problem in newer public health. J. Mt Sinai Hosp. N.Y. 20, 118-139 (1953
12. Wong, N. D. & Levy, D. Legacy of the Framingham Heart Study: Rationale, design, initial findings and implications. Global Heart 8, 3-9 (2013
13. Dawber, T. R., Meadors, G. F. & Moore, Jr. F.E. Epidemiological approaches to heart disease: The Framingham Study. Am. J. Pub. Health Nations Health 41, 279-281 (1951
14. Dawber, T. R., Moore, F. E. Jr & Mann, G. V. Coronary heart disease in the Framingham Study. Am. J. Pub. Health Nations Health 47, 4-24 (1957
15. Kannel, W. B., Dawber, T. R., Kagan, A., Revotskie, N. & Stokes, J. 3rd. Factors of risk in development of coronary heart disease-six year follow-up experience: The Framingham Study. Ann. Intern. Med. 55, 33-50 (1961
16. Kannel, W. B., Castelli, W. P., Gordon, T. & McNamara, P. M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study. Ann. Intern. Med. 74, 1-12 (1971
17. Doyle, J. T., Dawber, T. R., Kannel, W. B., Heslin, A. S. & Kahn, H. A. Cigarette smoking and coronary heart disease: Combined experience of the Albany and Framingham studies. N. Engl. J. Med. 266, 796-801 (1962
18. Kagan, A., Gordon, T., Kannel, W. B. & Dawber, T. R. Proceedings of the Council for High Blood Pressure Research (American Heart Association, 1959
19. Castelli, W. P. et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256, 2835-2838 (1986
20. Kannel, W. B. & McGee, D. L. Diabetes and cardiovascular disease. The Framingham study. JAMA 241, 2035-2038 (1979
21. Preis, S. R. et al. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: The Framingham Heart Study. Circulation 113, 2914-2918 (2006
22. Levy, D. et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 36, 477-483 (2000
23. Levy, D. et al. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 41, 677-687 (2009
24. Kannel, W. B., Wolf, P. A., Verter, J. & McNamara, P. M. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA 214, 301-310 (1970
25. McKee, P. A., Castelli, W. P., McNamara, P. M. & Kannel, W. B. The Natural history of congestive heart failure: The Framingham study. N. Engl. J. Med. 285, 1441-1446 (1971
26. Wilson, P. W. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837-1847 (1998
27. Kannel, W. B. Sixty years of preventive cardiology: A Framingham perspective. Clin. Cardiol. 34, 342-343 (2011
28. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): A major international collaboration. J. Clin. Epidemiol. 41, 105-114 (1988
29. Tunstall-Pedoe, H. et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10 year results from 37 WHO MONICA Project populations. Lancet 353, 1547-1557 (1999
30. Kuulasmaa, K. et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355, 675-687 (2000
31. Tustall-Pedoe, H. et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 355, 688-700 (2000
32. Evans, A. et al. Trends in coronary risk factors in the WHO MONICA Project. Int. J. Epidemiol. 30, S35-S40 (2001
33. Leupker, R. V. WHO MONICA Project: What have we learned and where to go from here? Public Health Reviews 33, 373-396 (2012
34. Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 364, 937-952 (2004
35. Rosengren, A. et al. for the INTERHEART investigators. Association of psychosocial risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries) (the INTERHEART study): Case-control study. Lancet 364, 953-962 (2004
36. Teo, K., Chow, C. K., Vaz, M., Rangarajan, S. & Yusuf, S. The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic noncommunicable disease in low , middle , and high-income countries. Am. Heart J. 158, 1-7 (2009
37. Teo, K. et al. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high , middle , and low-income countries: The Prospective Urban Rural Epidemiology (PURE) study. JAMA 309, 1613-1621 (2013
38. Yusuf, S. et al. Prospective Urban Rural Epidemiology (PURE) Study Investigators. Use of secondary prevention drugs for cardiovascular disease in the community in high income, middle-income, and low-income countries (the PURE Study): A prospective epidemiological survey. Lancet 378, 1231-1243 (2011
39. Worth, R. M., Kato, H., Rhoads, G. G., Kagan, K. & Syme, S. L. Epidemiologic studies for coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: Mortality. Am. J. Epidemiol. 102, 481-490 (1975
40. Sekikawa, A. et al. A natural experiment in cardiovascular epidemiology in the early 21st century. Heart 89, 255-257 (2003
41. Rose, G. et al. Myocardial ischaemia, risk factors and death from coronary heart disease. Lancet 1, 105-109 (1977
42. Ebi-Kryston, K. L. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all cause in the Whitehall Study. J. Clin. Epidemiol. 41, 251-260 (1988
43. Smith, G. D., Shipley, M. J., Marmot, M. G. & Rose, G. Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA 267, 70-76 (1992
44. Marmot, M. G. et al. Health inequalities among British civil servants: The Whitehall II study. Lancet 337, 1387-1393 (1991
45. Kivimäki, M. et al. Justice at work and reduced risk of coronary heart disease among employees: The Whitehall II Study. Arch. Intern. Med. 165, 2245-2251 (2005
46. Bosma, H. et al. Low job control and risk of coronary heart disease in Whitehall II (prospective cohort) study. BMJ 314, 558-565 (1997
47. Talmud, P. J. et al. Utility of genetic and non-genic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 340, b4838 (2010
48. Sigurdsson, E., Thorgeirsson, G., Sigvaldason, H. & Sigfusson, N. Prevalence of coronary heart disease in Icelandic men 1968-1986. The Reykjavik Study. Eur. Heart J. 14, 584-591 (1993
49. Sigurdsson, E. Thorgeirsson, G., Sigvaldason, H., & Sigfusson, N. Unrecognized myocardial infarction: Epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann. Intern. Med. 122, 96-102 (1995
50. Harris, T. B. et al. Age, Gene/Environment Susceptibility-Reykjavik Study: Multidisciplinary applied phenomics. Am. J. Epidemiol. 165, 1076-1087 (2007
51. Vidal, J. S. et al. Coronary artery calcium, brain function and structure: The AGES-Reykjavik Study. Stroke 41, 891-897 (2010
52. Olafsdottir, E. et al. Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: The population-based AGES-Reykjavik Study. BMJ Open 1, e000132 (2011
53. Assmann, G. & Schulte, H. The Prospective Cardiovascular Münster (PROCAM) study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am. Heart J. 116, 1713-1724 (1988
54. Assmann, G. & Schulte, H. The Prospective Cardiovascular Münster Study: Prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension. Am. J. Cardiol. 59, 9G 17G (1987
55. Assmann, G., Cullen, P. & Schuklte, H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 105, 310-315 (2002
56. Hense, H. W. et al. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany-results from the MONICA Augsburg and the PROCAM cohorts. Eur. Heart J. 24, 937-945 (2003
57. Friedman, G. D. et al. CARDIA: Study design, recruitment, and some characteristics of the examined subjects. J. Clin. Epidemiol. 41, 1105-1116 (1988
58. Gardin, J. M. et al. Echocardiographic design of a multicenter investigation of free-living elderly subjects: The Cardiovascular Health Study. J. Am. Soc. Echocardiogr. 5, 63-72 (1992
59. Carr, J. J. et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: Standardized protocol of Multiethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) Study. Radiology 234, 35-43 (2005
60. Bild, D. E. et al. Prevalence and correlates of coronary calcification in black and white young adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler. Thromb. Vasc. Biol. 21, 852-857 (2001
61. Truesdale, K. P. et al. Changes in risk factors for cardiovascular disease by baseline weight status in young adults who maintain or gain weight over 15 years: The CARDIA study. Int. J. Obes. 30, 1397-1407 (2006
62. Bibbins-Domingo, K. et al. Racial differences in incident heart failure among young adults. N. Engl. J. Med. 360, 1179-1190 (2009
63. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. Am. J. Epidemiol. 129, 687-702 (1989
64. Heiss, G. et al. Carotid atherosclerosis measured by B mode ultrasound in populations: Associations with cardiovascular risk factors in the ARIC study. Am. J. Epidemiol. 134, 250-256 (1991
65. Nambi, V. et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: The ARIC (Atherosclerosis Risk in Communities) study. J. Am. Coll. Cardiol. 55, 1600-1607 (2010
66. Nambi, V. et al. The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease riskprediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 222, 135-137 (2012
67. Folsom, A. R. et al. Community prevalence of ideal cardiovascular health by the American Heart Association definition and relation with cardiovascular disease incidence. J. Am. Coll. Cardiol. 57, 1690-1696 (2011
68. Lee, E. T. et al. The Strong Heart Study. A study of cardiovascular disease in American Indians: Design and methods. Am. J. Epidemiol. 132, 1141-1155 (1990
69. Lee, E. T. et al. Incidence of diabetes in American Indians of tree geographic areas: The Strong Heart Study. Diabetes Care 25, 49-54 (2002
70. Resnick, H. E. et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: The Strong Heart Study. Diabetes Care 26, 861-867 (2003
71. Fried, L. P. et al. The Cardiovascular Health Study: Design and rationale. Ann. Epidemiol. 1, 263-276 (1991
72. Bild, D. E. et al. Age-related trends in cardiovascular morbidity and physical functioning in the elderly: The Cardiovascular Health Study. J. Am. Geriatr. Soc. 41, 1047-1056 (1993
73. Fried, L. P. et al. Risk factors for 5 year mortality in older adults: The Cardiovascular Health Study. JAMA 279, 585-592 (1998
74. Psaty, B. M. et al. Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study. JAMA 268, 1287-1291 (1992
75. Taylor, H. A. Jr et al. Toward resolution of cardiovascular health disparities in African Americans: Design and methods of the Jackson Heart Study. Ethn. Dis. 15 (Suppl. 6), S6 4-S6 17 (2005
76. Liu, J. et al. Pericardial adipose tissue, atherosclerosis, and cardiovascular disease risk factors: The Jackson Heart Study. Diabetes Care 33, 1635-1639 (2010
77. Bidulescu, A. et al. Associations of adiponectin and leptin with incident coronary heart disease and ischemic stroke in African Americans: The Jackson Heart Study. Front. Public Health 1, 16 (2013
78. Bild, D. E. et al. Multi-Ethnic Study of Atherosclerosis:objectives and design. Am. J. Epidemiol. 156, 871-881 (2002
79. Bluemke, D. A. et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: The MESA (Multi-Ethnic Study of Atherosclerosis) study. J. Am. Coll. Cardiol. 52, 2148-2155 (2008
80. Bild, D. E. et al. Ethnic differences in coronary calcification: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111, 1313-1320 (2005
81. Detrano, R. et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med. 358, 1336-1345 (2008
82. Polonsky, T. S. et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 303, 1610-1616 (2010
83. Malik, S. et al. Impact of subclinical atherosclerosis on cardiovascular disease events in persons with metabolic syndrome and diabetes: The Multiethnic Study of Atherosclerosis. Diabetes Care 34, 2285-2290 (2011
84. Yeboah, J. et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 308, 788-795 (2012
85. Sorlie, P. D. et al. Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann. Epidemiol. 20, 629-641 (2010
86. Daviglus, M. L. et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA 308, 1775-1784 (2012
87. Kaptoge, S. et al. C reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-Analysis. Lancet 375, 132-140 (2010
88. Kaptoge, S. et al. C reactive protein, fibrinogen, and cardiovascular disease prediction. N. Engl. J. Med. 367, 1310-1320 (2012
89. Di Angelantonio, E. et al. Lipid-related markers and cardiovascular disease prediction. JAMA 307, 2499-2506 (2012
90. Wormser, D. et al. Separate and combined associations of body mass index and abdominal adiposity with cardiovascular disease: A collaborative analysis of 58 prospective studies. Lancet 377, 1085-1095 (2011
91. Seshasai, S. R. et al. Diabetes mellitus, fasting glucose and risk of cause-specific death. N. Engl. J. Med. 364, 829-841 (2011
92. Palomaki, G. E., Melillo, S. & Bradley, L. A. Association between 9p21 genomic markers and heart disease: A meta-Analysis. JAMA 303, 648-656 (2010
93. Levy, D. et al. Framingham Heart Study 100K Project: Genome-wide associations for blood pressure and arterial stiffness. BMC Med. Genet. 8 (Suppl. 1), S3 (2007
94. Lieb, W. et al. Genetic predisposition to higher blood pressure increases coronary artery disease risk. Hypertension 61, 995-1001 (2013
95. Sarwar, N. et al. Interleukihn 6 receptor pathways in coronary heart disease: A collaborative meta-Analysis of 82 studies. Lancet 379, 1205-1213 (2012
96. Willer, C. J. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274-1283 (2013
97. Baigent, C. et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-Analysis of data from 170 participants in 26 randomised trials. Lancet 376, 1670-1681 (2010
98. Mihaylova, B. et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-Analysis of individual data from 27 randomised trials. Lancet 380, 581-590 (2012
99. Stone, N. J. et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc. 2013.11.002
100. Lewington, S., Clarke, R., Qizilbash, N., Peto, R. & Collins, R. Age-specific relevant of usual blood pressure to vascular mortality: A meta-Analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903 (2002
101. Turnbull, F. for the Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure lowering regimens on major cardiovascular events: Results from prospective-Designed overviews of randomized trials. Lancet 362, 1527-1535 (2003
102. Antithrombotic Trialists' Collaboration. Collaborative meta-Analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324, 71-86 (2002
103. Baigent, C. et al. Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-Analysis of individual participant data from randomized trials. Lancet 373, 1849-1860 (2009
104. Califf, R. M., Armstrong, P. W., Carver, J. R., D'Agostino, R. B. & Strauss, W. E. 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for coronary disease events. Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J. Am. Coll. Cardiol. 27, 1007-1019 (1996
105. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486-2497 (2001
106. Greenland, P. et al. 2010 ACCF/AHA Guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 56, 50-103 (2010
107. Kannel, W. B., McGee, D. & Gordon, T. A general cardiovascular risk profile: The Framingham Study. Am. J. Cardiol. 38, 46-51 (1976
108. D'Agostino, R. B. Sr et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 117, 743-753 (2008
109. The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur. J. Prev. Cardiol. 19, 585-667(2012
110. Halcox, J. P. et al. Reclassification of European patients' cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm. Eur. J. Prev. Cardiol. http://dx.doi.org/10.1177/2047487313507680
111. Pencina, M. J., D'Agostino, R. B. Sr, Larson, M. G., Massaro, J. M. & Vasan, R. S. Predicting the 30-year risk of cardiovascular disease: The Framingham Heart Study. Circulation 119, 3078-3084 (2009
112. Lloyd-Jones, D. M., Larson, M. G., Beiser, A. & Levy, D. Lifetime risk of developing coronary heart disease. Lancet 353, 89-92 (1999
113. Berry, J. D. et al. Lifetime risks of cardiovascular disease. N. Engl. J. Med. 366, 321-329 (2012
114. Goff, D. C. Jr et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2013.11.005
115. Rosendorff, C. et al. Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 115, 2761-2788 (2007
116. Grundy, S. M. et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart Lung and Blood Institute Scientific Statement. Circulation 112, 2735-2752 (2005
117. Epstein, F. H. Coronary heart disease epidemiology revisited. Clinical and community aspects. Circulation 48, 185-194 (1973
118. Pearson, T. A. Public policy approaches to the prevention of heart disease and stroke. Circulation 124, 2560-2571 (2011
119. Pearson, T. A. et al. American Heart Association Council on Epidemiology and Prevention. American Heart Association guide for improving cardiovascular health at the community level, 2013 update: A scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation 127, 1730-1753 (2013
120. Hartley, L. et al. Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD009874. http://dx.doi.org/10.1002/14651858. CD009874.pub2
121. Rees, K. et al. 'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD009825. http://dx.doi.org/10.1002/14651858.CD009825. pub2
122. Li, J. & Siegrist, J. Physical activity and risk of cardiovascular disease-A meta-Analysis of prospective cohort studies. Int. J. Environ. Res. Public Health 9, 391-407 (2012
123. Smith, S. C. Jr et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J. Am. Coll. Cardiol. 58, 2432-2446 (2011
124. Smith, S. C. Jr et al. Our time: A call to save preventable death from cardiovascular disease (heart disease and stroke). J. Am. Coll. Cardiol. 60, 2343-2348 (2012
125. Pocock, S. J., Shaper, A. G., Cook, D. G., Phillips, A. N. & Walker, M. Social class differences in ischaemic heart disease in British men. Lancet 2, 197-201 (1987
126. Hjermann, I., Leren, P., Norman, N., Helgeland, A. & Holme, I. Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: The Oslo study. Scand. J. Clin. Lab. Invest. 40, 89-94 (1980
127. Knutsen, S. F. & Knutsen, R. The Tromsø Heart Study: Family approach to interventionon CHD. Feasibility of risk factor reduction in high-risk persons-project description. Scand. J. Soc. Med. 17, 109-119 (1989
128. Carlson, L. A. & Lindstedt, S. The Stockholm prospective study. 1. The initial values for plasma lipids. Acta Med. Scand. Suppl. 493, 1-135 (1968
129. Rosenman, R. H. et al. Coronary heart disease in the Western collaborative group study. A follow-up experience of two years. JAMA 195, 86-92 (1966
130. Barrett-Connor, E. & Wingard, D. L. Sex differential in ischemic heart disease mortality in diabetics: A prospective population-based study. Am. J. Epidemiol. 118, 489-496 (1983
131. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. NHANES I Epidemiologic Followup Study (NHEFS) [online], http://www.cdc.gov/nchs/nhanes/nhefs/nhefs.htm
132. Colditz, G. A., Manson, J. E. & Hankinson, S. E. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J. Womens Health 6, 49-62 (1997
133. Hennekens, C. H. & Eberlein, K. A randomized trial of aspirin and beta-carotene among US physicians. Prev. Med. 14, 165-168 (1985
134. Feinleib, M. et al. The NHLBI twin study of cardiovascular disease risk factors: Methodology and summary of results. Am. J. Epidemiol. 106, 284-285 (1977
135. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control. Clin. Trials 19, 61-109 (1998
136. Huang, Z. et al. A north-south comparison of blood pressure and factors related to blood pressure in the People's Republic of China: A report from the PRC-USA Collaborative Study of Cardiovascular Epidemiology. J. Hypertens. 12, 1103-1112 (1994.